A phase I study of concurrent 9-nitro-20(s)-camptothecin (9NC/Orathecin) and radiation therapy in the treatment of locally advanced adenocarcinoma of the pancreas

9NC, 1 mg/m2/day, can be given concurrently with radiation with acceptable toxicity.